DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Retrovir (Zidovudine) - Adverse Event Reports - Life Threatening Events - Alanine Aminotransferase Increased

 



Index of reports > Cases resulting in life threatening events (13) > Cases with Alanine Aminotransferase Increased (3)

Below is the selection of adverse event reports related to Retrovir (Zidovudine) that includes cases resulting in life threatening events where reactions include alanine aminotransferase increased.

Adverse event in female receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-30

Patient: female, weighing 1.0 kg (2.2 pounds)

Adverse reactions / side effects: Ileostomy, Premature Baby, Alanine Aminotransferase Increased, Thrombocythaemia, Necrotising Colitis, Speech Disorder, Colectomy Total, Blood Creatinine Increased, Enterocolitis, Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Zerit
    Dosage: exposure during gestation.

Videx
    Dosage: exposure during gestation.

Invirase
    Dosage: exposure during gestation.

Norvir
    Dosage: exposure during gestation.

Retrovir
    Dosage: exposure during delivery.
    Start date: 1999-07-02
    End date: 1999-07-02

Retrovir
    Dosage: initiated at 8 mg/kg/day, 6 mg/kg/day from 7/6/99, then 1.4 mg/kg twice daily from 7/11/99.
    Indication: Prophylaxis
    Start date: 1999-07-02
    End date: 1999-08-10

Retrovir
    Administration route: Oral
    Start date: 1999-07-07
    End date: 1999-07-18

Other drugs received by patient: Bactrim; Triflucan; Loxen; Celestene; Salbutamol



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a health professional (non-physician/pharmacist) from Malaysia on 2007-02-12

Patient: male

Adverse reactions / side effects: Diarrhoea Neonatal, Hyperlactacidaemia, Anion GAP Increased, Coagulopathy, Dyskinesia, Blood Albumin Decreased, Prothrombin Time Prolonged, Neonatal Disorder, Activated Partial Thromboplastin Time Prolonged, Caesarean Section, Hepatic Encephalopathy, Vertical Infection Transmission, Gamma-Glutamyltransferase Increased, Developmental Delay, HIV Infection, Fever Neonatal, Abdominal Distension, Alanine Aminotransferase Increased, Vomiting Neonatal, Convulsion, Drug Exposure During Pregnancy, Dehydration, Aspartate Aminotransferase Increased, Maternal Condition Affecting Foetus, Ammonia Increased, Feeding Disorder

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Retrovir
    Dosage: oral
    Administration route: Oral

Epivir
    Dosage: transplacentary
    Indication: HIV Infection

Stavudine
    Dosage: transplacentary
    Indication: HIV Infection

Nevirapine
    Dosage: transplacentary
    Indication: HIV Infection

Retrovir
    Dosage: transplacentary
    Indication: HIV Infection



Adverse event in male receiving Retrovir (Zidovudine)

Reported by a individual with unspecified qualification from Japan on 2007-01-12

Patient: male

Adverse reactions / side effects: Agranulocytosis, Hepatic Function Abnormal, Gamma-Glutamyltransferase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-01-11
    End date: 2005-10-04

Zerit
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1996-06-22
    End date: 2004-08-19

Retrovir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-01-11
    End date: 1999-02-18

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-01-11
    End date: 2005-10-11

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009